Literature DB >> 31295563

m6A methylation modulates adipogenesis through JAK2-STAT3-C/EBPβ signaling.

Ruifan Wu1, Guanqun Guo1, Zhen Bi1, Youhua Liu1, Yuanling Zhao1, Nana Chen1, Fengqin Wang1, Yizhen Wang1, Xinxia Wang2.   

Abstract

N6-methyladenosine (m6A), the most abundant internal mRNA modification in eukaryotes, plays a vital role in regulating adipogenesis. However, its underlying mechanism remains largely unknown. Here, we reveal that deletion of m6A demethylase FTO in porcine and mouse preadipocytes inhibits adipogenesis through JAK2-STAT3-C/EBPβ signaling. Mechanistically, FTO deficiency suppresses JAK2 expression and STAT3 phosphorylation, leading to attenuated transcription of C/EBPβ, which is essential for the early stage of adipocyte differentiation. Using dual-luciferase assay, we validate that knockdown of FTO reduces expression of JAK2 in an m6A-dependent manner. Furthermore, we find that m6A "reader" protein YTHDF2 directly targets m6A-modified transcripts of JAK2 and accelerates mRNA decay, which results in decreased JAK2 expression and inactivated JAK2-STAT3-C/EBPβ signaling, thereby inhibiting adipogenesis. Collectively, our results provide a novel insight into the molecular mechanism of m6A methylation in post-transcriptional regulation of JAK2-STAT3-C/EBPβ signaling axis and highlight the crucial role of m6A modification and its modulators in adipogenesis.
Copyright © 2019 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adipogenesis; FTO; JAK2; STAT3; YTHDF2; m(6)A

Mesh:

Substances:

Year:  2019        PMID: 31295563     DOI: 10.1016/j.bbagrm.2019.06.008

Source DB:  PubMed          Journal:  Biochim Biophys Acta Gene Regul Mech        ISSN: 1874-9399            Impact factor:   4.490


  10 in total

1.  FTO Suppresses STAT3 Activation and Modulates Proinflammatory Interferon-Stimulated Gene Expression.

Authors:  Michael J McFadden; Matthew T Sacco; Kristen A Murphy; Moonhee Park; Nandan S Gokhale; Kim Y Somfleth; Stacy M Horner
Journal:  J Mol Biol       Date:  2021-09-16       Impact factor: 5.469

Review 2.  m6A-binding proteins: the emerging crucial performers in epigenetics.

Authors:  Yanchun Zhao; Yuanfei Shi; Huafei Shen; Wanzhuo Xie
Journal:  J Hematol Oncol       Date:  2020-04-10       Impact factor: 17.388

Review 3.  Novel Insights into Adipogenesis from the Perspective of Transcriptional and RNA N6-Methyladenosine-Mediated Post-Transcriptional Regulation.

Authors:  Tongxing Song; Yang Yang; Siwen Jiang; Jian Peng
Journal:  Adv Sci (Weinh)       Date:  2020-09-03       Impact factor: 16.806

Review 4.  Regulatory mechanisms of the early phase of white adipocyte differentiation: an overview.

Authors:  M Audano; S Pedretti; E De Fabiani; N Mitro; D Caruso; M Crestani
Journal:  Cell Mol Life Sci       Date:  2022-02-20       Impact factor: 9.207

5.  TIPE1 inhibits osteosarcoma tumorigenesis and progression by regulating PRMT1 mediated STAT3 arginine methylation.

Authors:  Minghao Yang; Yuzhu Zhang; Guangping Liu; Ziqian Zhao; Jigang Li; Le Yang; Kui Liu; Wei Hu; Yunwei Lou; Jie Jiang; Qing Liu; Peiqing Zhao
Journal:  Cell Death Dis       Date:  2022-09-23       Impact factor: 9.685

Review 6.  Roles of N6-Methyladenosine (m6A) in Stem Cell Fate Decisions and Early Embryonic Development in Mammals.

Authors:  Meng Zhang; Yanhui Zhai; Sheng Zhang; Xiangpeng Dai; Ziyi Li
Journal:  Front Cell Dev Biol       Date:  2020-08-11

Review 7.  Function and evolution of RNA N6-methyladenosine modification.

Authors:  Zhi-Man Zhu; Fu-Chun Huo; Dong-Sheng Pei
Journal:  Int J Biol Sci       Date:  2020-04-15       Impact factor: 6.580

Review 8.  Dysregulations of Functional RNA Modifications in Cancer, Cancer Stemness and Cancer Therapeutics.

Authors:  Mohammad Burhan Uddin; Zhishan Wang; Chengfeng Yang
Journal:  Theranostics       Date:  2020-02-10       Impact factor: 11.556

Review 9.  Epigenetic regulation of N6-methyladenosine modifications in obesity.

Authors:  Mingli Sun; Xinan Zhang
Journal:  J Diabetes Investig       Date:  2021-06-03       Impact factor: 4.232

10.  Fat mass and obesity-associated protein (FTO) mediates signal transducer and activator of transcription 3 (STAT3)-drived resistance of breast cancer to doxorubicin.

Authors:  Yan Wang; Zhiqiang Cheng; Jing Xu; Meina Lai; Liming Liu; Min Zuo; Lin Dang
Journal:  Bioengineered       Date:  2021-12       Impact factor: 3.269

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.